Clinical Trials Logo

Clinical Trial Summary

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using basal-bolus insulin therapy.


Clinical Trial Description

A randomized controlled trial (RCT) will evaluate 13 weeks of home use of the t:slim X2 insulin pump with Control-IQ technology 1.5 in adults with type 2 diabetes age 18 and older using basal-bolus insulin therapy compared with continuation of pre-study insulin delivery plus continuous glucose monitoring (CGM). At least 300 participants will complete the trial at up to 25 clinical sites, across the United States and Canada. The primary outcome is change in hemoglobin A1c (HbA1c) compared between the intervention and control group. The secondary endpoints will be tested for superiority, with a hierarchical testing approach. Additional outcomes are exploratory. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05785832
Study type Interventional
Source Tandem Diabetes Care, Inc.
Contact
Status Active, not recruiting
Phase N/A
Start date June 1, 2023
Completion date September 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04522882 - Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1 N/A
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Not yet recruiting NCT05185518 - Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes N/A
Recruiting NCT05893797 - A Study of LY8888AX in Participants Using a Connected Insulin Management Platform N/A
Completed NCT02791295 - Lifestyle Intervention in Type 2 Diabetes N/A
Withdrawn NCT04957173 - Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project N/A
Not yet recruiting NCT05317585 - Continuous Glucose Monitor Use in Pregnancy N/A
Completed NCT05372471 - Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes. N/A
Completed NCT05111301 - Control-IQ Technology in Individuals With Type 2 Diabetes N/A
Active, not recruiting NCT04585191 - Reducing Treatment Risk in Older Adults With Diabetes N/A
Recruiting NCT04871438 - Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM) N/A
Completed NCT06060743 - Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management N/A
Completed NCT04005261 - C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes
Terminated NCT03980236 - Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study] N/A
Not yet recruiting NCT06185296 - The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy N/A
Completed NCT03437525 - Peer Support in Diabetes Management - Insulin Peer Support N/A
Active, not recruiting NCT03070106 - Diabetes: Functional Medicine Approach vs. Usual Care N/A
Completed NCT02060916 - Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes Phase 2
Recruiting NCT04945070 - INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi Phase 4
Recruiting NCT05795439 - The CARING Study: Creating and Restoring Health Through Nutrition Guidance N/A